Injection amifostine, this product is a normal reproductive cell protective film, which is mainly used for the adjuvant treatment of various types of cancer. Before radiotherapy and chemotherapy for patients with lung cancer, ovarian cancer, breast cancer, nasopharyngeal cancer, bone tumors, gastrointestinal tumors, hematological tumors, and other types of cancer, this product can significantly reduce the toxic and side effects of chemotherapy drugs on kidney function, bone marrow, heart, ear, and central nervous system without reducing the efficacy of chemotherapy drugs. The application of this product before radiotherapy and chemotherapy can significantly reduce the occurrence of oral dryness and mucositis. Below is the instruction for injection of amifostine.

Characteristics

This product is a white crystalline powder or a small piece of freeze-dried matter; has a peculiar smell.

Application field

This product is a normal reproductive cell protective film, which is mainly used for the adjuvant treatment of various types of cancer. Before radiotherapy and chemotherapy for patients with lung cancer, ovarian cancer, breast cancer, nasopharyngeal cancer, bone tumors, gastrointestinal tumors, hematological tumors, and other types of cancer, this product can significantly reduce the toxic and side effects of chemotherapy drugs on kidney function, bone marrow, heart, ear, and central nervous system without reducing the efficacy of chemotherapy drugs. The application of this product before radiotherapy and chemotherapy can significantly reduce the occurrence of oral dryness and mucositis. Below is the instruction for injection of amifostine.

Model and specification

0.4g

Required dosage for operation

1. For chemotherapy patients, the initial dose of this product is 500-600mg/㎡ based on body surface area, dissolved in 50ml of 0.9% sodium chloride injection, and intravenous infusion 30 minutes before the start of radiotherapy and chemotherapy, completed within 15 minutes.

2. For radiotherapy patients, the initial dose of this product is 200-300mg/㎡ based on body surface area, dissolved in 50ml of 0.9% sodium chloride injection, and intravenous infusion 15 minutes before the start of radiotherapy and chemotherapy, completed within 15 minutes.

3. Highly recommend using antiemetic therapy, that is, to inject dexamethasone 5-10mg and 5-HT3 receptor antagonist before and after this product.

4. If the occlusion pressure is significantly lower than the listed baseline value in the table, stop the infusion of this product.

Baseline occlusion pressure (mmHg)